Axogen (AXGN) Current Deferred Tax Assets (2010 - 2011)

Axogen's (AXGN) quarterly Current Deferred Tax Assets came in at $18000.0 in Q2 2011, down 96.65% quarter-over-quarter from $538000.0 in Q4 2010.

Axogen (AXGN) Current Deferred Tax Assets (2010 - 2011) Analysis & Trends

Axogen's Current Deferred Tax Assets history runs 2 years deep, the most recent figure standing at $18000.0 for Q2 2011.

On a quarterly basis, Current Deferred Tax Assets changed N/A year-over-year to $18000.0 in Q2 2011; TTM through Jun 2011 was $18000.0, a N/A change from a year earlier, with the FY2010 full-year figure at $538000.0, changed N/A from the prior year.
Current Deferred Tax Assets declined to $18000.0 in Q2 2011 per AXGN's latest filing, from $538000.0 in the prior quarter.
Across five years, Current Deferred Tax Assets topped out at $538000.0 in Q4 2010 and bottomed at $18000.0 in Q2 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-
10	Axogen	2.05 Bn	1.95 Bn	46.19 Mn

Download Data